Adrian Rawcliffe

Adrian Rawcliffe has an estimated net worth of $2.13 Million. This is based on reported shares across multiple companies, which include Adaptimmune Therapeutics PLC, Wave Life Sciences Ltd., and HUMAN GENOME SCIENCES INC.

2019 was Adrian Rawcliffe's most active year for acquiring shares with 7 total transactions. Adrian Rawcliffe's most active month to acquire stocks was the month of December. 2025 was Adrian Rawcliffe's most active year for disposing of shares, totalling 7 transactions. Adrian Rawcliffe's most active month to dispose stocks was the month of December. 2025 saw Adrian Rawcliffe paying a total of $250,740.00 for 8,702,980 shares, this is the most they've acquired in one year. In 2018 Adrian Rawcliffe cashed out on 600,000 shares for a total of $1,026,000.00, their largest year based on trade value.